FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis

PHASE2UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

May 31, 2023

Study Completion Date

August 31, 2023

Conditions
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Interventions
DRUG

Placebo

Placebo BID for 13 weeks

DRUG

FM101 150 mg BID

FM101 (150 mg) BID for 13 weeks

DRUG

FM101 300 mg BID

FM101 (300 mg) BID for 13 weeks

Trial Locations (12)

Unknown

RECRUITING

Semmelweis Egyetem I. sz. Sebészeti és Intervenciós Gasztroenterológiai Klinika, Budapest

RECRUITING

West Health Kft.,, Budapest

RECRUITING

Krakowskie Centrum Medyczne sp z o.o., Krakow

RECRUITING

ID Clinic Arkadiusz Pisula, Mysłowice

RECRUITING

Warsaw IBD Point Profesor Kierkus, Warsaw

RECRUITING

Centrum Medyczne K2J2, Wołomin

RECRUITING

Centrum Badan Klinicznych Piotr Napora lekarze, Wroclaw

RECRUITING

Hospital Universitari Vall d Hebron, Barcelona

RECRUITING

Hospital Universitario Marqués de Valdecilla, Santander

RECRUITING

Hospital Universitario Virgen del Rocio (HUVR), Seville

RECRUITING

Consorcio Hospital General Universitario de Valencia, Valencia

RECRUITING

Hospital Clnico Universitario de Valencia, Valencia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Future Medicine

INDUSTRY